CJPRY(CJPRY)
CJPRY
No analyst ratings available
No analyst price targets available for CJPRY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $2.06T | $2.11T | $2.16T | $2.23T | $2.28T |
| Low | $2.03T | $2.08T | $2.13T | $2.20T | $2.25T |
| High | $2.09T | $2.14T | $2.20T | $2.26T | $2.31T |
| EBITDA Avg | $1.49T | $1.52T | $1.56T | $1.61T | $1.64T |
| Low | $1.47T | $1.50T | $1.54T | $1.59T | $1.62T |
| High | $1.51T | $1.55T | $1.59T | $1.64T | $1.67T |
| EBIT Avg | $1.41T | $1.45T | $1.49T | $1.53T | $1.56T |
| Low | $1.40T | $1.43T | $1.47T | $1.51T | $1.54T |
| High | $1.44T | $1.47T | $1.51T | $1.56T | $1.59T |
| Net Income Avg | $506.31B | $522.76B | $525.97B | $537.45B | $543.00B |
| Low | $498.02B | $514.20B | $517.35B | $528.64B | $534.10B |
| High | $516.76B | $533.55B | $536.82B | $548.54B | $554.20B |
| EPS Avg | $261.38 | $269.88 | $271.53 | $277.46 | $280.32 |
| Low | $257.10 | $265.46 | $267.08 | $272.91 | $275.73 |
| High | $266.78 | $275.45 | $277.13 | $283.18 | $286.11 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 5 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $509.07B | $565.92B | $526.92B |
| Low | $502.71B | $558.85B | $520.34B |
| High | $515.20B | $572.74B | $533.27B |
| EBITDA Avg | $367.59B | $408.64B | $380.48B |
| Low | $363.00B | $403.54B | $375.73B |
| High | $372.02B | $413.57B | $385.07B |
| EBIT Avg | $349.89B | $388.97B | $362.16B |
| Low | $345.53B | $384.11B | $357.64B |
| High | $354.11B | $393.66B | $366.53B |
| Net Income Avg | $163.22B | $114.90B | $78.66B |
| Low | $160.57B | $113.04B | $77.39B |
| High | $165.77B | $116.70B | $79.90B |
| EPS Avg | $85.93 | $60.49 | $41.41 |
| Low | $84.53 | $59.51 | $40.74 |
| High | $87.27 | $61.44 | $42.06 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |